Express Interest in Neurocarrus

Neurocarrus

Neurocarrus

Neurocarrus, with a valuation of $11.25 million, is raising funds on Wefunder. The company has developed the drug candidate N-001 to provide neuron-specific pain relief without risk of addiction. Neurocarrus’ N-001 is a first-in-class, long-acting aesthetic-like drug that could reduce or avoid opioi...

0/500

Password should be at least 8 characters long.

Cancel

We use cookies on this site to enhance your user experience and analyze site traffic. By clicking "Accept", you consent to our use of cookies. Learn more